Scar Treatment

Scar Treatment Market Size Valuation Will Reach to US$ 61.9 Billion by 2030 Scar Treatment Market Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 - 2030

Share This Article

As per the experts, the scar treatment market is predicted to record a growth rate of 10.7% from 2021-2030 and is projected to reach US$ 61.9 billion by 2030.

The study provides the overall revenue of the global scar treatment market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global scar treatment market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the scar treatment industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

We customize your report according to your research need. REQUEST SAMPLE OR CUSTOMIZED COPY OF THIS REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1303

Crucial factors accountable for market growth are:

  • Rising personal disposable income
  • Growing concerns among the young population regarding their looks
  • Rising prevalence of skin diseases
  • Technological advancements in the scar treatment industry
  • Growing number of road accidents
  • Easy availability of topical scar treatment products as OTC products
  • Rising penetration of healthcare units in emerging countries

Report Highlights

  • By treatment type, the laser segment is anticipated to grow at a rapid pace during the forecast period. This is attributable to the growing awareness regarding the laser skin treatment. Moreover, it provides rapid, effective, and painless treatment of scars.
  • By scar type, the hypertrophic & keloid is anticipated to be the most opportunistic segment. The growing prevalence of keloid scars especially in the developed regions like North America and Europe, is estimated to boost the segment growth throughout the forecast period.
  • By end use, the home-use segment led the global scar treatment market with remarkable revenue share in 2020. The increasing popularity of e-pharmacy and other digital pharmacy platforms coupled with the increased penetration of retail pharmacies across the world has significantly contributed towards the establishment of this segment as a leading segment in the past.

Scope of the Scar Treatment Market Report

Report Coverage Details
Market Size in 2020 US$ 20.6 billion
Growth Rate from 2021 to 2030 CAGR of 10.7%
Base Year 2021
Forecast Period 2021 to 2030
Largest Market North America
Segments Covered Treatment Type, Scar Type, End Use Type, Region
Companies Mentioned Bausch Health Companies, Inc., Candela Corp., Sonoma Pharmaceuticals, Inc., Hologic, Inc., Johnson & Johnson, Quantum, Inc., CCA Industries, Inc., Avita Medical Ltd., Revitol Corp., Scarguard Labs, LLC.

Regional Snapshots

North America is the dominating scar treatment market owing to the increased prevalence of scars in the region. According to the NCBI, around 100 million patients acquire scars owing to the elective operations and after-trauma operations in the developed nations, annually. It is estimated that around 11 million people have keloid scars and around 4 million people have burns, of which over 70% of the affected population consists of children. Hence, the growing prevalence of scars coupled with improved healthcare access and demand for aesthetic improvement has fostered the growth of the scar treatment market in North America.

Asia Pacific is estimated to be the fastest-growing market owing to the increased prevalence of road accidents. As per the WHO, the maximum road accidents occur in the low and middle income countries due to the lack of better roadways. Moreover, in the nations like India, where the population of youth is higher than any other nation are expected to foster the market growth. The young population concerned about their looks is significantly propelling the demand for the scar treatment products in the region.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global scar treatment market are as follows:

  • Bausch Health Companies, Inc.
  • Candela Corp.
  • Sonoma Pharmaceuticals, Inc.
  • Hologic, Inc.
  • Johnson & Johnson
  • Quantum, Inc.
  • CCA Industries, Inc.
  • Avita Medical Ltd.
  • Revitol Corp.
  • Scarguard Labs, LLC.

Segments Covered in the Report

By Treatment Type

  • Topical
  • Laser
  • Surface
  • Surgical
  • Injectable

By Scar Type

  • Acne & Atrophic
  • Stretch Marks
  • Hypertrophic & Keloid
  • Contracture

By End Use

  • Dermatology Clinics
  • Home-Use
  • Hospitals

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Some of the key highlights of the report are:

  • Market Demand Outlook – The report offers refined forecasts on potential growth prospects for the market. Based on data derived after thorough research by a team of expert analysis, Precedence Research presents the most precise rate of growth for the market for the assessment period starting from 2021 – 2030.
  • Supply Chain Analysis – The purpose of the survey is to help companies identify potential scope for supply chain expansion. The study also presents analysis of unprecedented threats.
  • Competitive Landscape Analysis – Some of the leading companies operating in the scar treatment market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Why should you invest in this report?

If you are aiming to enter the global scar treatment market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for scar treatment are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Scar Treatment Market, By Treatment

7.1. Scar Treatment Market, by Treatment Type, 2021-2030

7.1.1. Topical

7.1.1.1. Market Revenue and Forecast (2019-2030)

7.1.2. Laser

7.1.2.1. Market Revenue and Forecast (2019-2030)

7.1.3. Surface

7.1.3.1. Market Revenue and Forecast (2019-2030)

7.1.4. Surgical

7.1.4.1. Market Revenue and Forecast (2019-2030)

7.1.5. Injectable

7.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Scar Treatment Market, By End Use

8.1. Scar Treatment Market, by End Use, 2021-2030

8.1.1. Dermatology Clinics

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Home-Use

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Hospitals

8.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Scar Treatment Market, By Scar 

9.1. Scar Treatment Market, by Scar, 2021-2030

9.1.1. Acne & Atrophic

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Stretch Marks

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Hypertrophic & Keloid

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Contracture

9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Scar Treatment Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.1.2. Market Revenue and Forecast, by End Use (2019-2030)

10.1.3. Market Revenue and Forecast, by Scar (2019-2030)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.1.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.1.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.1.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.1.5.3. Market Revenue and Forecast, by Scar (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.2.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.3. Market Revenue and Forecast, by Scar (2019-2030)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.2.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.2.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.5.3. Market Revenue and Forecast, by Scar (2019-2030)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.2.6.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.6.3. Market Revenue and Forecast, by Scar (2019-2030)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.2.7.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.7.3. Market Revenue and Forecast, by Scar (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.3.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.3. Market Revenue and Forecast, by Scar (2019-2030)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.3.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.3.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.5.3. Market Revenue and Forecast, by Scar (2019-2030)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.3.6.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.6.3. Market Revenue and Forecast, by Scar (2019-2030)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.3.7.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.7.3. Market Revenue and Forecast, by Scar (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.4.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.4.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.5.3. Market Revenue and Forecast, by Scar (2019-2030)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.4.6.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.6.3. Market Revenue and Forecast, by Scar (2019-2030)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.4.7.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.7.3. Market Revenue and Forecast, by Scar (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.5.3. Market Revenue and Forecast, by Scar (2019-2030)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.5.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.5.4.3. Market Revenue and Forecast, by Scar (2019-2030)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Treatment (2019-2030)

10.5.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.5.5.3. Market Revenue and Forecast, by Scar (2019-2030)

Chapter 11. Company Profiles

11.1. Bausch Health Companies, Inc.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Candela Corp.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Sonoma Pharmaceuticals, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Hologic, Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Johnson & Johnson

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Quantum, Inc.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. CCA Industries, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Avita Medical Ltd.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Revitol Corp.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Scarguard Labs, LLC.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1303

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →